Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2013, Article ID 761060, 7 pages
http://dx.doi.org/10.1155/2013/761060
Review Article

Recent Advances in NSAIDs-Induced Enteropathy Therapeutics: New Options, New Challenges

1Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, 814 Siksadong, Ilsandonggu, Goyang 410-773, Republic of Korea
2Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, 126-1 Anam-dong 5 ga, Seongbuk-gu, Seoul 136-705, Republic of Korea

Received 4 June 2013; Revised 2 August 2013; Accepted 13 August 2013

Academic Editor: Gerassimos Mantzaris

Copyright © 2013 Yun Jeong Lim and Hoon Jai Chun. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Y. Graham, A. R. Opekun, F. F. Willingham, and W. A. Qureshi, “Visible small-intestinal mucosal injury in chronic NSAID users,” Clinical Gastroenterology and Hepatology, vol. 3, no. 1, pp. 55–59, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Maiden, B. Thjodleifsson, A. Theodors, J. Gonzalez, and I. Bjarnason, “A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy,” Gastroenterology, vol. 128, no. 5, pp. 1172–1178, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. Tibble, G. Sigthorsson, R. Foster et al., “High prevalence of NSAID enteropathy as shown by a simple faecal test,” Gut, vol. 45, no. 3, pp. 362–366, 1999. View at Google Scholar · View at Scopus
  4. S. Fujimori, K. Gudis, Y. Takahashi et al., “Distribution of small intestinal mucosal injuries as a result of NSAID administration,” European Journal of Clinical Investigation, vol. 40, no. 6, pp. 504–510, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Matsumoto, T. Kudo, M. Esaki et al., “Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study,” Scandinavian Journal of Gastroenterology, vol. 43, no. 4, pp. 490–496, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Maiden, “Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy,” Journal of Gastroenterology, vol. 44, no. 19, pp. 64–71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Smale, J. Tibble, G. Sigthorsson, and I. Bjarnason, “Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine,” Best Practice and Research: Clinical Gastroenterology, vol. 15, no. 5, pp. 723–738, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Zuccaro, “Epidemiology of lower gastrointestinal bleeding,” Best Practice and Research: Clinical Gastroenterology, vol. 22, no. 2, pp. 225–232, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Lanas and F. Sopeña, “Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications,” Gastroenterology Clinics of North America, vol. 38, no. 2, pp. 333–352, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Scarpignato and R. H. Hunt, “Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention,” Gastroenterology Clinics of North America, vol. 39, no. 3, pp. 433–464, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Keum and H. J. Chun, “Capsule endoscopy and double balloon enteroscopy for obscure gastrointestinal bleeding: which is better?” Journal of Gastroenterology and Hepatology, vol. 26, no. 5, pp. 794–795, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. B. J. Lee, H. J. Chun, J. S. Koo et al., “Analysis of the factors that affect the diagnostic yield of capsule endoscopy in patients with obscure gastrointestinal bleeding,” The Korean Journal of Gastroenterology, vol. 49, no. 2, pp. 79–84, 2007. View at Google Scholar · View at Scopus
  13. S. C. Park, H. J. Chun, C. D. Kang, and D. Sul, “Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury,” World Journal of Gastroenterology, vol. 17, no. 42, pp. 4647–4653, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. J. Lim and C. H. Yang, “Non-steroidal anti-inflammatory drug-induced enteropathy,” Clinical Endoscopy, vol. 45, no. 2, pp. 138–144, 2012. View at Publisher · View at Google Scholar
  15. T. Arakawa, T. Watanabe, T. Tanigawa et al., “Small intestinal injury caused by NSAIDs/aspirin: finding new from old,” Current Medicinal Chemistry, vol. 19, no. 1, pp. 77–81, 2012. View at Google Scholar · View at Scopus
  16. J. L. Wallace and J. G. P. Ferraz, “New pharmacologic therapies in gastrointestinal disease,” Gastroenterology Clinics of North America, vol. 39, no. 3, pp. 709–720, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. G. A. Goel, A. Deshpande, R. Lopez, G. S. Hall, D. van Duin, and W. D. Carey, “Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression,” Clinical Gastroenterology and Hepatology, vol. 10, no. 4, pp. 422–427, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. W. Kim, K. L. Lee, J. B. Jeong et al., “Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea,” World Journal of Gastroenterology, vol. 16, no. 28, pp. 3573–3577, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. L. E. Targownik, W. D. Leslie, K. S. Davison et al., “The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian multicentre osteoporosis study (CaMos),” The American Journal of Gastroenterology, vol. 107, no. 9, pp. 1361–1369, 2012. View at Publisher · View at Google Scholar
  20. T. Hagiwara, K. Mukaisho, T. Nakayama, H. Sugihara, and T. Hattori, “Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori,” Gut, vol. 60, no. 5, pp. 624–630, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Wallace, S. Syer, E. Denou et al., “Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis,” Gastroenterology, vol. 141, no. 4, pp. 1314.e5–1322.e5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. J. Lim, T. M. Phan, E. J. Dial, D. Y. Graham, and L. M. Lichtenberger, “In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine,” Digestion, vol. 86, no. 2, pp. 171–177, 2012. View at Publisher · View at Google Scholar
  23. Y. Yoda, K. Amagase, S. Kato et al., “Prevention by lansoprazole, a proton pump inhibitor, of indomethacin-induced small intestinal ulceration in rats through induction of heme oxygenase-1,” Journal of Physiology and Pharmacology, vol. 61, no. 3, pp. 287–294, 2010. View at Google Scholar · View at Scopus
  24. K. Takeuchi, A. Tanaka, S. Kato, K. Amagase, and H. Satoh, “Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage,” Clinica Chimica Acta, vol. 411, no. 7-8, pp. 459–466, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Laine, S. P. Curtis, M. Langman et al., “Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac,” Gastroenterology, vol. 135, no. 5, pp. 1517–1525, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. L. Goldstein, G. M. Eisen, B. Lewis, I. M. Gralnek, S. Zlotnick, and J. G. Fort, “Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo,” Clinical Gastroenterology and Hepatology, vol. 3, no. 2, pp. 133–141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Maiden, B. Thjodleifsson, A. Seigal et al., “Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study,” Clinical Gastroenterology and Hepatology, vol. 5, no. 9, pp. 1040–1045, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Laine, E. S. Maller, C. Yu, H. Quan, and T. Simon, “Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial,” Gastroenterology, vol. 127, no. 2, pp. 395–402, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. D. J. Watson, S. E. Harper, P. L. Zhao, H. Quan, J. A. Bolognese, and T. J. Simon, “Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis,” Archives of Internal Medicine, vol. 160, no. 19, pp. 2998–3003, 2000. View at Google Scholar · View at Scopus
  30. F. K. L. Chan, A. Lanas, J. Scheiman, M. F. Berger, H. Nguyen, and J. L. Goldstein, “Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial,” The Lancet, vol. 376, no. 9736, pp. 173–179, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Fujimori, T. Seo, K. Gudis et al., “Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy,” Gastrointestinal Endoscopy, vol. 69, no. 7, pp. 1339–1346, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Watanabe, S. Sugimori, N. Kameda et al., “Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study,” Clinical Gastroenterology and Hepatology, vol. 6, no. 11, pp. 1279–1282, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Niwa, M. Nakamura, N. Ohmiya et al., “Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study,” Journal of Gastroenterology, vol. 43, no. 4, pp. 270–276, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Fujimori, Y. Takahashi, K. Gudis et al., “Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy,” Journal of Gastroenterology, vol. 46, no. 1, pp. 57–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Mizukami, K. Murakami, T. Abe et al., “Aspirin-induced small bowel injuries and the preventive effect of rebamipide,” World Journal of Gastroenterology, vol. 17, no. 46, pp. 5117–5122, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Niwa, M. Nakamura, R. Miyahara et al., “Geranylgeranylacetone protects against diclofenac-induced gastric and small intestinal mucosal injuries in healthy subjects: a prospective randomized placebo-controlled double-blind cross-over study,” Digestion, vol. 80, no. 4, pp. 260–266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Endo, T. Higurashi, K. Hosono et al., “Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study,” Journal of Gastroenterology, vol. 46, no. 7, pp. 894–905, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Bjarnason, J. Hayllar, A. J. MacPherson, and A. S. Russell, “Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans,” Gastroenterology, vol. 104, no. 6, pp. 1832–1847, 1993. View at Google Scholar · View at Scopus
  39. K. Higuchi, E. Umegaki, T. Watanabe et al., “Present status and strategy of NSAIDs-induced small bowel injury,” Journal of Gastroenterology, vol. 44, no. 9, pp. 879–888, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. J. L. Wallace, “NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies,” The British Journal of Pharmacology, vol. 165, no. 1, pp. 67–74, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Konaka, S. Kato, A. Tanaka, T. Kunikata, R. Korolkiewicz, and K. Takeuchi, “Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats,” Pharmacological Research, vol. 40, no. 6, pp. 517–524, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. T. H. Kent, R. M. Cardelli, and F. W. Stamler, “Small intestinal ulcers and intestinal flora in rats given indomethacin,” The American Journal of Pathology, vol. 54, no. 2, pp. 237–249, 1969. View at Google Scholar · View at Scopus
  43. M. Uejima, T. Kinouchi, K. Kataoka, I. Hiraoka, and Y. Ohnishi, “Role of intestinal bacteria in ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug,” Microbiology and Immunology, vol. 40, no. 8, pp. 553–560, 1996. View at Google Scholar · View at Scopus
  44. T. Watanabe, K. Higuchi, A. Kobata et al., “Non-steroidal anti-inflammatory drug-induced small intestinal damage is toll-like receptor 4 dependent,” Gut, vol. 57, no. 2, pp. 181–187, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. I. Bjarnason, J. Hayllar, P. Smethurst, A. Price, and M. J. Gumpel, “Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy,” Gut, vol. 33, no. 9, pp. 1204–1208, 1992. View at Google Scholar · View at Scopus
  46. B. K. Reuter, N. M. Davies, and J. L. Wallace, “Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation,” Gastroenterology, vol. 112, no. 1, pp. 109–117, 1997. View at Google Scholar · View at Scopus
  47. Y. Zhou, E. J. Dial, R. Doyen, and L. M. Lichtenberger, “Effect of indomethacin on bile acid-phospholipid interactions: implication for small intestinal injury induced by nonsteroidal anti-inflammatory drugs,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 298, no. 5, pp. G722–G731, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. J. M. Barrios and L. M. Lichtenberger, “Role of biliary phosphatidylcholine in bile acid protection and nsaid injury of the lleal mucosa in rats,” Gastroenterology, vol. 118, no. 6, pp. 1179–1186, 2000. View at Google Scholar · View at Scopus
  49. L. M. Lichtenberger, M. Barron, and U. Marathi, “Association of phosphatidylcholine and nsaids as a novel strategy to reduce gastrointestinal toxicity,” Drugs of Today, vol. 45, no. 12, pp. 877–890, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. L. M. Lichtenberger, Z. M. Wang, J. J. Romero et al., “Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury,” Nature Medicine, vol. 1, no. 2, pp. 154–158, 1995. View at Google Scholar · View at Scopus
  51. L. M. Lichtenberger, Y. Zhou, V. Jayaraman et al., “Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine,” Biochimica et Biophysica Acta, vol. 1821, no. 7, pp. 994–1002, 2012. View at Publisher · View at Google Scholar
  52. F. L. Lanza, U. K. Marathi, B. S. Anand, and L. M. Lichtenberger, “Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients,” Alimentary Pharmacology and Therapeutics, vol. 28, no. 4, pp. 431–442, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. J. Lim, J. S. Lee, Y. S. Ku, and K. B. Hahm, “Rescue strategies against non-steroidal anti-inflammatory drug-induced gastroduodenal damage,” Journal of Gastroenterology and Hepatology, vol. 24, no. 7, pp. 1169–1178, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. J. L. Wallace and P. Del Soldato, “The therapeutic potential of NO-NSAIDs,” Fundamental and Clinical Pharmacology, vol. 17, no. 1, pp. 11–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Blackler, S. Syer, M. Bolla, E. Ongini, and J. L. Wallace, “Gastrointestinal-sparing effects of novel nsaids in rats with compromised mucosal defence,” PLoS ONE, vol. 7, no. 4, Article ID e35196, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Fiorucci, E. Antonelli, E. Distrutti et al., “Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs,” Gastroenterology, vol. 129, no. 4, pp. 1210–1224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. J. L. Wallace, “Hydrogen sulfide-releasing anti-inflammatory drugs,” Trends in Pharmacological Sciences, vol. 28, no. 10, pp. 501–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Montalto, N. Maggiano, R. Ricci et al., “Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells,” Digestion, vol. 69, no. 4, pp. 225–228, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Kamil, M. S. Geier, R. N. Butler, and G. S. Howarth, “Lactobacillus rhamnosus GG exacerbates intestinal ulceration in a model of indomethacin-induced enteropathy,” Digestive Diseases and Sciences, vol. 52, no. 5, pp. 1247–1252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Gotteland, S. Cruchet, and S. Verbeke, “Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans,” Alimentary Pharmacology and Therapeutics, vol. 15, no. 1, pp. 11–17, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Montalto, A. Gallo, V. Curigliano et al., “Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy—a randomized, double-blind, cross-over, placebo-controlled study,” Alimentary Pharmacology and Therapeutics, vol. 32, no. 2, pp. 209–214, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Lanas, L. A. García-Rodríguez, M. Polo-Tomás et al., “Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice,” The American Journal of Gastroenterology, vol. 104, no. 2, pp. 1633–1644, 2009. View at Publisher · View at Google Scholar